Quant Mid Cap Fund vs UTI - Mid Cap Fund
Quant Mid Cap Fund and UTI - Mid Cap Fund are both Mid Cap funds. As of 5 Nov 2026 (Direct plan, Growth option): 3-year CAGR +10.89% vs +11.92%, 5-year CAGR +14.70% vs +10.90%, volatility 17.57% vs 17.75%, maximum drawdown −33.43% vs −40.75%. Their portfolios overlap by 8.6% (6 stocks held by both).
Showing the Direct plan, Growth option. Portfolio, sector and market-cap figures are the same for every plan and option of a fund.
Key facts
| Quant Mid Cap | UTI - Mid Cap | |
|---|---|---|
| Fund house | quant Mutual Fund | UTI Mutual Fund |
| Compared as | Mid Cap | Mid Cap |
| NAV | ₹246.2400 | ₹344.9802 |
| NAV date | 5 Nov 2026 | 5 Nov 2026 |
| Launched (first NAV) | 7 Jan 2013 | 2 Jan 2013 |
| Track record | 13.8 yrs | 13.8 yrs |
| Fund size (AUM) | ₹7,654 Cr | — |
| Securities held | 35 | 82 |
| Portfolio as of | 30 Sep 2026 | 30 Sep 2026 |
| Fund page | Full record → | Full record → |
Returns
| Quant Mid Cap | UTI - Mid Cap | |
|---|---|---|
| 1 month | +0.69% | +1.64% |
| 3 months | −3.15% | −3.08% |
| 6 months | +0.26% | +0.54% |
| 1 year | +2.01% | +0.53% |
| 3 years (CAGR) | +10.89% | +11.92% |
| 5 years (CAGR) | +14.70% | +10.90% |
| 7 years (CAGR) | +23.49% | +18.72% |
| 10 years (CAGR) | +18.37% | +14.04% |
| Since launch (CAGR) | +16.28% | +17.63% |
| SIP return (XIRR, 5 years) ⓘ | +11.12% | +10.98% |
Up to one year: absolute return. Beyond one year: CAGR. Computed from each fund's own NAV history (AMFI), measured to the latest NAV.
Calendar-year returns
| Quant Mid Cap | UTI - Mid Cap | |
|---|---|---|
| 2026 (year to date) | +4.56% | +1.60% |
| 2025 | −4.46% | +0.72% |
| 2024 | +20.27% | +24.41% |
| 2023 | +36.40% | +31.73% |
| 2022 | +19.94% | +0.26% |
| 2021 | +53.85% | +44.44% |
Risk
| Quant Mid Cap | UTI - Mid Cap | |
|---|---|---|
| Volatility (annualised) ⓘ | 17.57% | 17.75% |
| Downside volatility ⓘ | 11.92% | 12.62% |
| Sharpe ratio ⓘ | 0.25 | 0.31 |
| Sortino ratio ⓘ | 0.37 | 0.43 |
| Maximum drawdown ⓘ | −33.43% | −40.75% |
| Recovery from that fall | 4 months | 8 months |
| Current fall from peak | −12.40% | −5.04% |
| Rolling 1-year return: worst | −29.52% | −28.62% |
| Rolling 1-year return: median | +12.63% | +15.33% |
| Rolling 1-year return: best | +121.29% | +127.40% |
| Share of 1-year periods with a loss | 22.31% | 17.78% |
Against each fund's benchmark
| Quant Mid Cap | UTI - Mid Cap | |
|---|---|---|
| Beta ⓘ | 0.89 | 0.95 |
| Alpha (Jensen's, annualised) ⓘ | −3.18% | −3.30% |
| R² ⓘ | 81.57 | 94.94 |
| Upside capture | 81.59% | 91.59% |
| Downside capture | 89.05% | 105.52% |
| Tracking error | 8.05% | 4.14% |
| Information ratio | -0.57 | -0.99 |
| Treynor ratio | 4.15 | 4.39 |
Portfolio
Asset mix
| Quant Mid Cap | UTI - Mid Cap | |
|---|---|---|
| Equity | 79.59% | 96.71% |
| Debt | 3.76% | 0.00% |
| Derivatives | 3.70% | 0.00% |
| Cash & equivalents | 0.90% | 1.95% |
| REITs / InvITs | 0.00% | 1.34% |
Market-cap split (share of fund assets)
| Quant Mid Cap | UTI - Mid Cap | |
|---|---|---|
| Large Cap | 14.02% | 11.32% |
| Mid Cap | 57.63% | 66.77% |
| Small Cap | 7.95% | 18.00% |
| Unclassified | 0.00% | 0.62% |
Concentration
| Quant Mid Cap | UTI - Mid Cap | |
|---|---|---|
| Top 10 holdings | 68.80% | 22.58% |
| Effective number of stocks ⓘ | 17.4 | 70.4 |
| Securities held | 35 | 82 |
Portfolio overlap: 8.6%
6 companies are held by both funds; by weight, 8.6% of the two portfolios is the same. That is a low overlap: the two portfolios are largely different.
| Held by both | Quant Mid Cap | UTI - Mid Cap |
|---|---|---|
| Aurobindo Pharma Limited | 10.71% | 2.24% |
| Bharat Heavy Electricals Limited | 5.03% | 1.78% |
| Persistent Systems Limited | 1.72% | 1.44% |
| IPCA Laboratories Limited | 2.01% | 1.16% |
| LG Electronics India Ltd | 5.09% | 1.02% |
| Tata Communications Limited | 8.49% | 1.00% |
Top 10 holdings
Quant Mid Cap
- Aurobindo Pharma Limited10.71%
- TREPS 01-Oct-2026 DEPO 109.46%
- Lloyds Metals And Energy Limited9.04%
- Tata Communications Limited8.49%
- Indus Towers Limited6.01%
- IRB Infrastructure Developers Limited5.70%
- LG Electronics India Ltd5.09%
- Bharat Heavy Electricals Limited5.03%
- Nippon Life India Asset Management Limited4.67%
- Premier Energies Limited4.59%
UTI - Mid Cap
- Coforge Limited3.01%
- AU Small Finance Bank Limited2.75%
- Blue Star Limited2.55%
- Aurobindo Pharma Limited2.24%
- Ajanta Pharma Limited2.15%
- APL Apollo Tubes Limited2.11%
- The Federal Bank Limited1.98%
- The Phoenix Mills Limited1.95%
- Info Edge (India) Limited1.92%
- Shriram Finance Limited1.92%
Sector exposure
| Quant Mid Cap | UTI - Mid Cap | |
|---|---|---|
| Pharmaceuticals & Biotechnology | 19.08% | 9.60% |
| Telecom - Services | 14.50% | 2.45% |
| Electrical Equipment | 9.62% | 5.56% |
| N.A. | 9.46% | 0.00% |
| Minerals & Mining | 9.04% | 0.00% |
| Banks | 0.47% | 8.54% |
| Industrial Products | 1.09% | 7.01% |
| Retailing | 0.00% | 6.50% |
| Finance | 0.00% | 6.21% |
| Consumer Durables | 5.09% | 6.15% |
| Construction | 5.70% | 0.00% |
| Auto Components | 0.56% | 5.50% |
| IT - Software | 1.72% | 5.34% |
| Capital Markets | 4.67% | 4.55% |
Questions people ask
What is the difference between Quant Mid Cap and UTI - Mid Cap returns?
As of 5 Nov 2026, Direct plan Growth option: 1-year return +2.01% vs +0.53%; 3-year CAGR +10.89% vs +11.92%; 5-year CAGR +14.70% vs +10.90%; 10-year CAGR +18.37% vs +14.04%. Past returns do not indicate future returns.
How do Quant Mid Cap and UTI - Mid Cap compare on risk?
Volatility (36 monthly returns, annualised) 17.57% vs 17.75%; Sharpe ratio 0.25 vs 0.31; Sortino ratio 0.37 vs 0.43; maximum drawdown −33.43% vs −40.75%; beta 0.89 vs 0.95.
How much do Quant Mid Cap and UTI - Mid Cap overlap?
By weight, 8.6% of the two portfolios is invested in the same companies; 6 stocks are held by both, the largest shared positions being Aurobindo Pharma Limited, Bharat Heavy Electricals Limited, Persistent Systems Limited. Based on the portfolios disclosed for Sep 2026 and Sep 2026.
What is the large, mid and small cap split of Quant Mid Cap and UTI - Mid Cap?
Quant Mid Cap: large cap 14.0%, mid cap 57.6%, small cap 8.0%. UTI - Mid Cap: large cap 11.3%, mid cap 66.8%, small cap 18.0% (share of the fund's assets, from its latest disclosed portfolio).
Is this a recommendation to choose one of these funds?
No. This page places the published figures of both funds side by side. It does not rank, rate or recommend either fund; which one suits an investor depends on their goals, horizon and risk tolerance.
More comparisons
Quant Mid Cap vs
All Mid Cap comparisons → · Compare up to six funds yourself → · Every fund in this category → · All comparisons →
Sources: NAV from AMFI; returns, risk and ratios computed by MF Analyser from each fund's NAV history (risk on 36 monthly returns, risk-free rate 6.5%); benchmark ratios against each fund's benchmark total-return index; portfolios from each fund house's monthly disclosure. Returns and ratios as of 5 Nov 2026. IDCW options show no return or risk figures because payouts reduce the NAV and AMFI's file carries no payout history to add back. This page compares published figures only — it does not rank, rate or recommend either fund. Past performance does not indicate future returns; mutual fund investments are subject to market risks.